ABCL logo

AbCellera Biologics Inc. (ABCL) EBIT

Annual EBIT:

-$301.15M-$78.09M(-35.01%)
December 31, 2024

Summary

  • As of today, ABCL annual earnings before interest & taxes is -$301.15 million, with the most recent change of -$78.09 million (-35.01%) on December 31, 2024.
  • During the last 3 years, ABCL annual EBIT has fallen by -$523.04 million (-235.71%).
  • ABCL annual EBIT is now -232.63% below its all-time high of $227.06 million, reached on December 31, 2022.

Performance

ABCL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

Quarterly EBIT:

-$76.28M-$26.69M(-53.83%)
September 30, 2025

Summary

  • As of today, ABCL quarterly earnings before interest & taxes is -$76.28 million, with the most recent change of -$26.69 million (-53.83%) on September 30, 2025.
  • Over the past year, ABCL quarterly EBIT has increased by +$17.39 million (+18.56%).
  • ABCL quarterly EBIT is now -128.29% below its all-time high of $269.59 million, reached on March 31, 2022.

Performance

ABCL Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

TTM EBIT:

-$261.28M+$17.39M(+6.24%)
September 30, 2025

Summary

  • As of today, ABCL TTM earnings before interest & taxes is -$261.28 million, with the most recent change of +$17.39 million (+6.24%) on September 30, 2025.
  • Over the past year, ABCL TTM EBIT has increased by +$46.79 million (+15.19%).
  • ABCL TTM EBIT is now -161.82% below its all-time high of $422.62 million, reached on September 30, 2022.

Performance

ABCL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ABCL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-35.0%+18.6%+15.2%
3Y3 Years-235.7%-244.6%-161.8%
5Y5 Years-10000.0%-4215.3%-5408.4%

ABCL EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-232.6%at low-244.6%+18.6%-161.8%+19.0%
5Y5-Year-232.6%at low-128.3%+18.6%-161.8%+19.0%
All-TimeAll-Time-232.6%at low-128.3%+18.6%-161.8%+19.0%

ABCL EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$76.28M(-53.8%)
-$261.28M(+6.2%)
Jun 2025
-
-$49.59M(+20.9%)
-$278.66M(+13.6%)
Mar 2025
-
-$62.66M(+13.9%)
-$322.53M(-2.5%)
Dec 2024
-$301.15M(-35.0%)
-$72.75M(+22.3%)
-$314.77M(-2.2%)
Sep 2024
-
-$93.66M(-0.2%)
-$308.06M(-14.4%)
Jun 2024
-
-$93.45M(-70.2%)
-$269.29M(-18.5%)
Mar 2024
-
-$54.89M(+16.9%)
-$227.23M(+4.2%)
Dec 2023
-$223.05M(-198.2%)
-$66.05M(-20.3%)
-$237.21M(-14.4%)
Sep 2023
-
-$54.89M(-6.8%)
-$207.38M(-108.0%)
Jun 2023
-
-$51.39M(+20.8%)
-$99.72M(-93.6%)
Mar 2023
-
-$64.87M(-79.1%)
-$51.51M(-118.2%)
Dec 2022
$227.06M(+2.3%)
-$36.22M(-168.6%)
$282.95M(-33.0%)
Sep 2022
-
$52.77M(+1756.3%)
$422.62M(+23.7%)
Jun 2022
-
-$3.19M(-101.2%)
$341.75M(+0.1%)
Mar 2022
-
$269.59M(+160.6%)
$341.51M(+36.6%)
Dec 2021
$221.90M
$103.45M(+468.2%)
$250.01M(-25.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$28.10M(-720.8%)
$334.48M(-7.3%)
Jun 2021
-
-$3.42M(-101.9%)
$360.81M(-0.1%)
Mar 2021
-
$178.08M(-5.2%)
$361.26M(+97.2%)
Dec 2020
$164.34M(+8309.0%)
$187.92M(>+9900.0%)
$183.17M(+3961.7%)
Sep 2020
-
-$1.77M(+40.6%)
-$4.74M(-59.4%)
Jun 2020
-
-$2.98M(>-9900.0%)
-$2.98M(>-9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
-$2.00M(-484.3%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2018
$521.00K
-
-
Dec 2018
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00

FAQ

  • What is AbCellera Biologics Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual EBIT year-on-year change?
  • What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
  • What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM EBIT year-on-year change?

What is AbCellera Biologics Inc. annual earnings before interest & taxes?

The current annual EBIT of ABCL is -$301.15M

What is the all-time high annual EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual earnings before interest & taxes is $227.06M

What is AbCellera Biologics Inc. annual EBIT year-on-year change?

Over the past year, ABCL annual earnings before interest & taxes has changed by -$78.09M (-35.01%)

What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of ABCL is -$76.28M

What is the all-time high quarterly EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly earnings before interest & taxes is $269.59M

What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?

Over the past year, ABCL quarterly earnings before interest & taxes has changed by +$17.39M (+18.56%)

What is AbCellera Biologics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of ABCL is -$261.28M

What is the all-time high TTM EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM earnings before interest & taxes is $422.62M

What is AbCellera Biologics Inc. TTM EBIT year-on-year change?

Over the past year, ABCL TTM earnings before interest & taxes has changed by +$46.79M (+15.19%)
On this page